Form 8-K - Current report:
SEC Accession No. 0001213900-24-110169
Filing Date
2024-12-18
Accepted
2024-12-18 16:30:27
Documents
13
Period of Report
2024-12-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0225122-8k_moonlake.htm   iXBRL 8-K 33792
  Complete submission text file 0001213900-24-110169.txt   205642

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE mltx-20241212.xsd EX-101.SCH 3021
3 XBRL LABEL FILE mltx-20241212_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE mltx-20241212_pre.xml EX-101.PRE 22363
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0225122-8k_moonlake_htm.xml XML 3555
Mailing Address DORFSTRASSE 29 ZUG V8 6300
Business Address DORFSTRASSE 29 ZUG V8 6300 41 41 510 8022
MoonLake Immunotherapeutics (Filer) CIK: 0001821586 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39630 | Film No.: 241559668
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)